Displaying items by tag: school of medicine

A new interactive dashboard from UAB and PathCheck Foundation will enable users to see the quantity and location of vaccines distributed across the country and world in real time.
Research found that gaining community members’ perspectives to identify barriers and facilitators to COVID-19, related to prevention, coping and testing, may potentially improve outcomes.
“These vaccines are our way out of the epidemic, and we want to do all we can to help get Alabama out of this as quickly as possible,” said Sarah Nafziger, M.D.
School of Medicine leadership recalls the struggles of the Black/African American community and the promise of the future in Black History Month
Altered epigenetic marks on ribosomal RNAs appear to create a pool of specialized ribosomes that can differentially regulate translation of specific messenger RNA.
In a new study from UAB, researchers found that eating grapes can protect skin from acute and chronic UV damage.
The School of Medicine’s Huntsville campus will expand the availability of clinical trials for residents of northern Alabama.
For women who are pregnant, lactating or trying to become pregnant, deciding whether to take the COVID vaccine when eligible can be a tough decision. UAB experts offer guidance.
Diethelm was chair of the UAB Department of Surgery, and built the UAB transplant program.
Elie is triple board-certified in emergency medicine and critical care, as well as hospice and palliative care medicine.
The starter online wellness program offers patients the opportunity to work with a health coach to assist them in improving and self-managing their health from home.
The vaccine most likely does not prevent spread of the virus, but probably does reduce the length of time an infected person sheds virus.
PAGER-CoV offers a data-driven, precision medicine approach to help researchers around the world better understand COVID-19.
The COVID-19 pandemic has disrupted normal blood donation patterns, leaving the nation’s blood supply perilously low.
With misinformation about COVID-19 vaccines rife, turn to trusted medical professionals at UAB’s Department of Medicine for the straight dope.
The 72-year-old patient was unable to mount her own immune defense against the SARS-CoV-2 virus because of chronic lymphocytic leukemia, which compromises normal immunity and immunoglobulin production.
If these hollow capsules are modified to target a solid tumor, PET imaging and therapeutic ultrasound can be used to rupture them and release an anticancer drug at ground zero.
Page 49 of 167